These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 3555051

  • 1. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ.
    Am J Med; 1987 Apr 27; 82(4A):295-300. PubMed ID: 3555051
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT, Ingerman MJ, Kaufman DH, Weiner P, Santoro J, Korzeniowski OM, Boscia J, Topiel M, Bush LM, Kaye D.
    Am J Med; 1987 Apr 27; 82(4A):262-5. PubMed ID: 3555045
    [Abstract] [Full Text] [Related]

  • 3. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H, Galanakis N.
    Am J Med; 1987 Apr 27; 82(4A):346-51. PubMed ID: 3555059
    [Abstract] [Full Text] [Related]

  • 4. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL, Berenson CS, Greco TP, Mangi RJ, Sims M, Thornton GF, Andriole VT.
    Am J Med; 1987 Apr 27; 82(4A):303-6. PubMed ID: 3555052
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL, Kathpalia SB, Sharifi R, Lolans VT, Jackson GG.
    Am J Med; 1987 Apr 27; 82(4A):290-4. PubMed ID: 3555050
    [Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 7. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Lesse AJ, Freer C, Salata RA, Francis JB, Scheld WM.
    Am J Med; 1987 Apr 27; 82(4A):247-53. PubMed ID: 3555043
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, NAUTICA Group.
    Int J Antimicrob Agents; 2005 Nov 27; 26(5):380-8. PubMed ID: 16243229
    [Abstract] [Full Text] [Related]

  • 9. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J, Kaul S, Khashab M, Fisher A, Kahn JB.
    Clin Ther; 2007 Oct 27; 29(10):2215-21. PubMed ID: 18042477
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ.
    Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037
    [Abstract] [Full Text] [Related]

  • 11. Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
    Giamarellou H, Daphnis E, Dendrinos C, Daikos GK.
    Drugs Exp Clin Res; 1985 Apr 27; 11(5):351-6. PubMed ID: 2941264
    [Abstract] [Full Text] [Related]

  • 12. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE, Jules K, Chin NX, Neu HC.
    Am J Med; 1987 Apr 27; 82(4A):336-8. PubMed ID: 3578324
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F, Torroba L, Buzón L, Martínez-Beltrán J, Loza E, Baquero F.
    Enferm Infecc Microbiol Clin; 1989 May 27; 7(5):261-5. PubMed ID: 2490722
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 27; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
    Valtonen V, Karppinen L, Kariniemi AL.
    Scand J Infect Dis Suppl; 1989 Nov 27; 60():79-83. PubMed ID: 2547245
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN, Tice AD, Marsh PK, Craven PC, Reilly PM, Bollinger M, Weinandt WJ.
    Am J Med; 1987 Apr 27; 82(4A):266-9. PubMed ID: 3555046
    [Abstract] [Full Text] [Related]

  • 17. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 27; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 18. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 27; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 19. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
    Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N.
    Am J Med; 1993 Mar 22; 94(3A):126S-130S. PubMed ID: 8452168
    [Abstract] [Full Text] [Related]

  • 20. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A, Naber KG, Bischoff W, Kullmann K.
    J Urol; 1997 Oct 22; 158(4):1494-9. PubMed ID: 9302150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.